GHRL and gastroesophageal junction adenocarcinoma: Our results for ghrelin and NCGC in ATBC replicate findings of a previous ATBC study, which investigated the association between serum ghrelin concentration and risk of gastric non-cardia adenocarcinoma (n = 261 cases) and esophagogastric junctional adenocarcinoma (n = 98 cases) [19].